EMPLOYMENT AGREEMENTEmployment Agreement • July 29th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
THIS EMPLOYMENT AGREEMENT (hereinafter “Agreement”) is entered into effective January 8, 2018 by and between Neurocrine Biosciences, Inc., 12780 El Camino Real, San Diego, California 92130 (hereinafter the “Company”), and Eiry Roberts (hereinafter “Executive”).
AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • July 29th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 to Collaboration and License Agreement (the "Amendment") entered into and effective on June 14, 2019 (the "Amendment Execution Date"), is made by and between Voyager Therapeutics, Inc., a Delaware corporation, having its principal place of business at 75 Sidney Street, Cambridge, MA 02139 ("Voyager"), and Neurocrine Biosciences, Inc., a Delaware corporation, having its principal place of business at 12780 El Camino Real, San Diego, CA 92130 ("Neurocrine"). Voyager and Neurocrine each may be referred to individually as a "Party", or together as the "Parties" Capitalized terms that are not defined in this Amendment shall have the meaning set forth in the Agreement (as defined below).
